EPO and cervical cancer: EPOR is expressed in cervical cancer, and the binding of erythropoietin (Epo) to its receptor induced cell proliferation; such cell response was related to the activation of JAK2, JAK3, STAT3, and STAT5, but not JAK1 and STAT1 in cervical cancer [84].